2003
DOI: 10.1016/s1386-6532(02)00267-6
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of a commercial ELISA for detecting Norwalk-like virus antigen in faeces

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
59
2
2

Year Published

2003
2003
2016
2016

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 96 publications
(66 citation statements)
references
References 19 publications
3
59
2
2
Order By: Relevance
“…13 In addition the gut flora in neonates and especially premature neonates could differ from infants and adults, thus explaining discrepancies between the DAKO kit's evaluation trials and our results, 14 but this explanation is unlikely given that this test is licensed for use in humans, including neonates. Based on the data described above, we question the high specificity of certain norovirus antigen EIA suggested in published investigations, 7,15 particularly considering the consequences, that is, the cost and logistic problems caused by the hygienic measures such as ward closures resulting from positive NoV results. We call for studies into the specificity of these tests for norovirus detection in stool samples from neonates.…”
Section: Discussionmentioning
confidence: 98%
“…13 In addition the gut flora in neonates and especially premature neonates could differ from infants and adults, thus explaining discrepancies between the DAKO kit's evaluation trials and our results, 14 but this explanation is unlikely given that this test is licensed for use in humans, including neonates. Based on the data described above, we question the high specificity of certain norovirus antigen EIA suggested in published investigations, 7,15 particularly considering the consequences, that is, the cost and logistic problems caused by the hygienic measures such as ward closures resulting from positive NoV results. We call for studies into the specificity of these tests for norovirus detection in stool samples from neonates.…”
Section: Discussionmentioning
confidence: 98%
“…First, collection of samples after onset of symptoms by three days may play a role in lack of detection of NoV (7). Furthermore, long periods of fecal storage before testing may also affect the level of the virus, as proteolytic degradation may take place (24,25).Collection and examination of fecal samples within 72 h after onset of viral gastroenteritis symptoms was done in our study, while in other studies samples were tested after storage for 2 to 3 years (26). Second, the outcome of all studies may be affected by differences in inclusion criteria fecal samples.…”
Section: In This Workmentioning
confidence: 99%
“…Some studies included specimens only when the clinical symptoms indicated a NoV outbreak. On the other hand some studies tested all samples that were sent to the laboratory (24,25). Finally, the discrepancy in sensitivity of Rida quick and EIA kit found in different studies may be explained by the antigenic diversity of NoV.Certain genotypes may be missed becausethese kits use monoclonal and polyclonal antibodies formed against virus-like particles representing GI and GII genotypes.…”
Section: In This Workmentioning
confidence: 99%
“…ELISAs can analyze a myriad of pathological samples using multiple screening modes and reporter molecules, giving the assay broad versatility, but their need for high viral loads [5,27,30] limits the assays' application mostly in clinical settings. Despite their relatively lower sensitivity when compared to PCR-based methods [5,20], ELISA-based assays have been used to detect norovirus in human stool samples [5,25,[36][37][38][39][40][41][42][43], human sera [29], and food samples [26,31,32,44,45] Using norovirus GI.1 (Norwalk) virus-like particles (VLPs) as a model viral system, the objective of this study was to develop and evaluate several ELISA-based assays for rapid detection of varying concentrations of GI.1 VLPs (0.037-3.7 μg/mL). HuNoV VLPs are replication-incompetent, macromolecular protein assemblies with capsid structures and antigenic properties resembling those of innate norovirus particles [46][47][48].…”
Section: Introductionmentioning
confidence: 99%